Narayanan K. Narayanan

1.7k total citations
22 papers, 1.2k citations indexed

About

Narayanan K. Narayanan is a scholar working on Molecular Biology, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, Narayanan K. Narayanan has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pharmacology and 5 papers in Geriatrics and Gerontology. Recurrent topics in Narayanan K. Narayanan's work include Inflammatory mediators and NSAID effects (7 papers), Sirtuins and Resveratrol in Medicine (5 papers) and Estrogen and related hormone effects (5 papers). Narayanan K. Narayanan is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Sirtuins and Resveratrol in Medicine (5 papers) and Estrogen and related hormone effects (5 papers). Narayanan K. Narayanan collaborates with scholars based in United States, India and Japan. Narayanan K. Narayanan's co-authors include Bhagavathi A. Narayanan, Bandaru S. Reddy, Dominick Nargi, Carla Randolph, Daniel W. Nixon, Brian Pittman, Barbara Simi, Gian G. Re, Kalyanam Nagabhushanam and Muhammed Majeed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Clinical Cancer Research.

In The Last Decade

Narayanan K. Narayanan

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narayanan K. Narayanan United States 16 529 241 183 169 155 22 1.2k
Bhagavathi A. Narayanan United States 22 723 1.4× 234 1.0× 312 1.7× 179 1.1× 444 2.9× 31 1.7k
Piwen Wang United States 23 766 1.4× 125 0.5× 241 1.3× 52 0.3× 124 0.8× 37 1.9k
Pedro Michaluart Brazil 16 708 1.3× 218 0.9× 148 0.8× 359 2.1× 51 0.3× 19 1.7k
Robert G. Britton United Kingdom 15 652 1.2× 143 0.6× 157 0.9× 455 2.7× 51 0.3× 27 1.4k
Alpna Tyagi United States 22 783 1.5× 281 1.2× 121 0.7× 177 1.0× 42 0.3× 31 1.4k
Husain Yar Khan United States 19 645 1.2× 119 0.5× 106 0.6× 57 0.3× 136 0.9× 57 1.3k
Jeong‐Hyeon Ko South Korea 22 1.1k 2.2× 167 0.7× 352 1.9× 271 1.6× 45 0.3× 38 2.1k
Do Young Lim United States 25 1.0k 2.0× 231 1.0× 214 1.2× 44 0.3× 50 0.3× 44 1.9k
Elumalai Perumal India 25 792 1.5× 137 0.6× 260 1.4× 27 0.2× 88 0.6× 61 1.7k

Countries citing papers authored by Narayanan K. Narayanan

Since Specialization
Citations

This map shows the geographic impact of Narayanan K. Narayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narayanan K. Narayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narayanan K. Narayanan more than expected).

Fields of papers citing papers by Narayanan K. Narayanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narayanan K. Narayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narayanan K. Narayanan. The network helps show where Narayanan K. Narayanan may publish in the future.

Co-authorship network of co-authors of Narayanan K. Narayanan

This figure shows the co-authorship network connecting the top 25 collaborators of Narayanan K. Narayanan. A scholar is included among the top collaborators of Narayanan K. Narayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narayanan K. Narayanan. Narayanan K. Narayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Majeed, Muhammed, et al.. (2023). Super Fruit Amla (Emblica officinalis, Gaertn) in Diabetes Management and Ensuing Complications: A Concise Review. SHILAP Revista de lepidopterología. 3(3). 329–352. 6 indexed citations
2.
Majeed, Muhammed, Shaheen Majeed, Narayanan K. Narayanan, & Kalyanam Nagabhushanam. (2019). A pilot, randomized, double‐blind, placebo‐controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytotherapy Research. 33(5). 1457–1468. 90 indexed citations
3.
Ashby, Charles R., et al.. (2015). Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer. Biochemical and Biophysical Research Communications. 463(3). 161–166. 34 indexed citations
4.
Narayanan, Narayanan K., Kazuhiro Kunimasa, Yukio Yamori, et al.. (2015). Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon‐26 tumor‐bearing mouse model in vivo. Cancer Medicine. 4(11). 1767–1780. 38 indexed citations
5.
Narayanan, Narayanan K., Kazuhiro Kunimasa, Lori Horton, et al.. (2015). Abstract B57: Gnetin C, a novel resveratrol dimer, targets pancreatic cancer metabolism. Cancer Research. 75(13_Supplement). B57–B57. 2 indexed citations
6.
Karthikeyan, Chandrabose, Crystal Lee, Joshua Moore, et al.. (2014). IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells. Bioorganic & Medicinal Chemistry. 23(3). 602–611. 40 indexed citations
7.
Narayanan, Bhagavathi A., et al.. (2013). Abstract B27: Tripterine induced cell cycle arrest and apoptosis is associated with modulation of PI3K-AKT-mTOR pathway in human pancreatic cancer cell. Cancer Prevention Research. 6(11_Supplement). B27–B27.
8.
Narayanan, Bhagavathi A., Nicole Doudican, Da-Zhong Xu, et al.. (2012). Antagonistic effect of small-molecule inhibitors of Wnt/β-catenin in multiple myeloma.. PubMed. 32(11). 4697–707. 13 indexed citations
9.
Narayanan, Narayanan K., Dominick Nargi, Carla Randolph, & Bhagavathi A. Narayanan. (2009). Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. International Journal of Cancer. 125(1). 1–8. 261 indexed citations
10.
Narayanan, Narayanan K., Dominick Nargi, Lori Horton, et al.. (2008). Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: Preventive effects of celecoxib. The Prostate. 69(2). 133–141. 27 indexed citations
11.
Narayanan, Narayanan K., et al.. (2007). Anticancer effects of licofelone (ML-3000) in prostate cancer cells.. PubMed. 27(4B). 2393–402. 25 indexed citations
12.
Hickey, Christina, et al.. (2006). Hexavalent chromium activates mediators of inflammation in human lung cells.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations
13.
Narayanan, Bhagavathi A., Narayanan K. Narayanan, Leland Davis, & Dominick Nargi. (2006). RNA interference–mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor. Molecular Cancer Therapeutics. 5(5). 1117–1125. 43 indexed citations
14.
Narayanan, Bhagavathi A., et al.. (2005). Adenocarcina of the mouse prostate growth inhibition by celecoxib: Downregulation of transcription factors involved in COX-2 inhibition. The Prostate. 66(3). 257–265. 57 indexed citations
15.
16.
Narayanan, Bhagavathi A., Narayanan K. Narayanan, Brian Pittman, & Bandaru S. Reddy. (2004). Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model. Clinical Cancer Research. 10(22). 7727–7737. 92 indexed citations
17.
Narayanan, Bhagavathi A., Narayanan K. Narayanan, Dhimant Desai, Brian Pittman, & Bandaru S. Reddy. (2004). Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and β-catenin pathways in colon cancer cells. Carcinogenesis. 25(12). 2443–2449. 68 indexed citations
18.
Narayanan, Bhagavathi A., Narayanan K. Narayanan, Gian G. Re, & Daniel W. Nixon. (2003). Differential expression of genes induced by resveratrol in LNCaP cells: P53‐mediated molecular targets. International Journal of Cancer. 104(2). 204–212. 125 indexed citations
19.
Narayanan, Bhagavathi A., Narayanan K. Narayanan, Barbara Simi, & Bandaru S. Reddy. (2003). Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells.. PubMed. 63(5). 972–9. 135 indexed citations
20.
Narayanan, Bhagavathi A., et al.. (2002). Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sciences. 70(15). 1821–1839. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhagavathi A. Narayanan Breakdown of academic impact, for papers by Piwen Wang Breakdown of academic impact, for papers by Pedro Michaluart Breakdown of academic impact, for papers by Robert G. Britton Breakdown of academic impact, for papers by Alpna Tyagi Breakdown of academic impact, for papers by Husain Yar Khan Breakdown of academic impact, for papers by Jeong‐Hyeon Ko Breakdown of academic impact, for papers by Do Young Lim Breakdown of academic impact, for papers by Elumalai Perumal
Rankless by CCL
2026